Hepatic inactivation of Leu-enkephalin

Regulatory Peptides

Volumn 67, Issue 2, 1996, Pages 85-92

  MacKinnon, Kathryn L ^a   Zuzel, Katherine A ^a   Billington, David ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Aminopeptidase; Leu enkephalin; Liver

Indexed keywords

AMINOPEPTIDASE; BESTATIN; LEUCINE ENKEPHALIN; MONOCLONAL ANTIBODY; TAUROCHOLIC ACID; THIORPHAN;

ANIMAL TISSUE; ARTICLE; DRUG UPTAKE; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IMMUNOCYTOCHEMISTRY; ISOTOPE LABELING; LIVER FUNCTION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANIMALS; ANTIGENS, CD13; BILIARY TRACT; BIOTRANSFORMATION; CELL MEMBRANE; ENKEPHALIN, LEUCINE; HYDROLYSIS; IODINE RADIOISOTOPES; LEUCINE; LIVER; MALE; MICE; PERFUSION; PROTEASE INHIBITORS; RATS; RATS, WISTAR; SUCCINIMIDES; TRITIUM; TYROSINE;

ANIMALIA;

EID: 0030568112     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(96)00117-6     Document Type: Article

References (35)

1. [1] Spiess, M., The asialoglycoprotein receptor: a model for endocytic receptors, Biochemistry. 29 (1990) 10009-10018.
2. [2] Coleman, R., Biochemistry of bile secretion, Biochem. J., 244 (1987) 249-261.
3. [3] Gores, G.J., LaRusso, N.F. and Miller, L.J., Hepatic processing of cholecystokinin peptides, 1. Structural specificity and mechanism of hepatic extraction. Am. J. Physiol., 250 (1986) G344-G349.
4. [4] Gores, G.J., Kost, L.J., Miller, L.J. and LaRusso, N.F., Processing of cholecystokinin by isolated liver cells, Am. J. Physiol., 257 (1989) G242-G248.
5. [5] Strunz, U.T., Thompson, M.R., Elashoft, J. and Grossman, M.I., Hepatic inactivation of gastrins of various chain lengths in dogs, Gastroenterology, 74 (1978) 550-553.
6. [6] Conlon, J.M., Whittaker, J., Hammond, V. and Alberti, K.G.M.M., Metabolism of somatostatin and its analogues by the liver, Biochim. Biophys. Acta, 677 (1981) 234-242.
7. [7] Fricker, G., Dubost, V., Schwab, D., Bruns, C. and Thiele, C., Heterogeneity in hepatic transport of somatostatin analogue peptides, Hepatology, 20 (1994) 191-200.
8. [8] Hambrook, J.M., Morgan, B.A., Rance, M.J. and Smith, C.F.C., Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates, Nature, 262 (1976) 782-783.
9. 3H]methionine-enkephalin by various rat tissues in vivo and in vitro, Life Sci., 21 (1977) 907-914.
10. [10] Shipp, M.A., Stefano, G.B., Switzer, S.N., Griffin, J.D. and Reinhertz., E.L., CD-10 (CALLA)/Neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration and adhesion proteins and is itself regulated by neutrophil activation, Blood, 78 (1991) 1834-1841.
11. [11] Van den Bergh, P., Rozing, J. and Nagelkerken, S., Opioid peptides as cytokines in T-cell activation, Adv. Neuroimmunol., 1 (1991) 189-203.
12. [12] Thornton, J.R. and Losowsky, M.S., Plasma leucine enkephalin is increased in liver disease, Gut, 30 (1989) 1392-1395.
13. [13] Thornton, J.R. and Losowsky, M.S., Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine, J. Hepatol., 8 (1989) 53-59.
14. [14] Swain, M.G., Rothman, R.B., Xu. H., Vergalla, J., Bergasa, N.V. and Jones, E.A., Endogenous opioids accumulate in plasma in a rat model of acute cholestasis, Gastroenterology, 103, (1992) 630-635.
15. [15] Jones, E.A. and Bergasa, N.V., The pruritus of cholestasis: from bile acids to opiate agonists, Hepatology, 11 (1990) 884-887.
16. [16] Bergasa, N.V., Alling, D.W., Talbot, T.L., Swain, M.G., Yurdaydin, C., Turner, M.L., Schmitt, J.M., Walker, E.C. and Jones, E.A., Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomised controlled study, Ann. Int. Med., 123 (1995) 161-167.
17. [17] Kunz, J., Krause, D., Kremer, M. and Dermietzel, R., The 140-kDa protein of blood brain barrier-associated pericytes is identical to aminopeptidae N, J. Neurochem., 62 (1994) 2375-2386.
18. [18] Wolfe, M.M., Bougoulias, M. and McGuigan, J.E., Cholecystokinin binding and degradation by isolated rat liver cells, Regul. Pept., 27 (1990) 27-36.
19. [19] Billington, D., Chard, P.S. and Clayton, M., Effects of butylated hydroxytoluene upon protein transport in the isolated perfused rat liver, Biochem. Pharmacol., 39 (1990) 1624-1627.
20. [20] Hunter, W.M. and Greenwood, F.C., Preparation of iodine-131 labelled human growth hormone of high specific activity, Nature, 194 (1962) 495-496.
21. [21] Roman, L.M. and Hubbard, A.L., A domain specific marker for the hepatocyte plasma membrane. II. Ultrastuctural localisation of leucine aminopeptidase to the bile canalicular domain of isolate rat liver plasma membranes, J. Cell Biol., 98 (1984) 1488-1496.
22. [22] Zuzel, K.A., Graham, J.M., Hryszko, J., Billington, D. and Turner, A.J., Peptidase content of the bile canalicular membrane, Biochem. Soc. Trans., 23 (1995) 306S.
23. [23] De la Baume, S., Gros, C., Yi, C.C., Chaillet, P., Marcais-Collado, H., Costentin, J. and Schwartz, J.C., Selective participation of both 'enkephalinase' and aminopeptidase activities in the metabolism of endogenous enkephalins, Life Sci., 31 (1982) 1753-1756.
24. 5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies, Mol. Pharmacol., 29 (1985) 281-287.
25. [25] Tieku, S. and Hooper, N.M., Inhibition of aminopeptidases N, A and W: a re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme, Biochem. Pharmacol., 44 (1992) 1725-1730.
26. [26] Barclay, R.K. and Phillips, M.A., Inhibition of enkephalin-degrading aminopeptidase activity by certain peptides, Biochem. Biophys. Res. Commun., 96 (1980) 1732-1738.
27. [27] Barelli, H., Woskowska, Z., Cipris, S., Fox-Threlkeld, J.E., Daniel, E.E., Vincent, J.P. and Checler, F., Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo study, J. Pharmacol. Exp. Ther., 275 (1995) 1300-1307.
28. [28] Howell, S., Murray, H., Scott, C.S., Turner, A.J. and Kenny, A.J., A highly sensitive ELISA for endopeptidase 24.11, the common acute-lymphoblastic-leukaemia antigen (CALLA, CD-10, applicable to material of porcine and human origin, Biochem, J., 278 (1991) 417-421.
29. [29] Bartles, J.R., Feracci, H.M., Stieger, B. and Hubbard, A.L., Biogenesis of the rat hepatocyte plasma membrane in vivo: comparison of the pathways taken by apical and basolateral proteins using subcellular fractionation, J. Cell Biol., 105 (1987) 1241-1251.
30. [30] Stieger, B., Meier, P.J. and Landmann, L., Effect of obstructive cholestasis on membrane traffic and domain-specific expression of plasma membrane proteins in rat liver parenchymal cells, Hepatology, 20 (1994) 201-212.
31. [31] Gore, S., Morris, A.I., Gilmore, I.T., Maltby, P.J., Thornback, J.R. and Billington, D., Differences in the intracellular processing of the radiolabel following the uptake of iodine-125-and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver, J. Nucl. Med., 32 (1991) 506-512.
32. [32] Schiff, J.M., Fisher, M.M. and Underdown, B.J., Receptor mediated biliary transport of immunoglobulin A and asialoglycoprotein: sorting and mis-sorting of ligands revealed by two radiolabelling methods, J. Cell Biol., 98 (1984) 79-89.
33. [33] Lowe, P.J., Kan, K.S., Barnwell, S.G., Sharma, R.K. and Coleman, R., Transcytosis and paracellular movements of horse radish peroxidase across liver parenchymal tissue from blood to bile: effects of alpha-napthylisothiocyanate and colchicine, Biochem. J., 229 (1985) 529-537.
34. [34] Roda, E., Aldini, R., Mazzella, G., Festi, D., Bazzoli, F. and Roda, A., Hepatic secretion of bile acids. In: N. Tavolini and P.D. Berk (Eds.), Hepatic Transport and Bile Secretion: Physiology and Pathophysiology, Raven Press, New York, NY, 1993, pp. 553-569.
35. [35] Ziegler, K., Frimmer, M., Kessler, H., Damm, I., Eiermann, V., Koll, S. and Zarbock, J., Modified somatostatins as inhibitors of a multispecific transport system for bile acids and phallotoxins in isolated hepatocytes, Biochim. Biophys. Acta, 845 (1985) 86-93.